Home/Search
2020 Scientific Sessions
The Low-Risk TAVR Patient: Considerations in 2020
This activity is supported by an unrestricted educational grant from Medtronic. No in-kind commercial support was received.
Critical Review of the Evidence: Bicuspid in Low-Risk Patients
John K. Forrest, MD
, Yale University, New Haven, CT
View Recording
Case Reviews From Low Risk Bicuspid Trial
Stanley J. Chetcuti, M.D., FSCAI
, The University of Michigan, Ann Arbor, MI
View Recording
Treating Low-Risk Patients: Why Maximizing Hemodynamic and Avoiding PPM Should Become a Priority
Hasan Jilaihawi, M.D.
, NYU Langone Medical Center, New York, NY
View Recording
How to Optimize Coronary Intervention Therapy in TAVR
James E. Harvey, M.D., FSCAI
, WellSpan York Hospital, Red Lion, PA
View Recording
See more of:
Satellite Sessions
<< Previous Satellite
|
Next Satellite >>